Vanessa Quick
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- Vasculitis and related conditions 11
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Susan P. Mollan (5 shared papers)Alexandra Jean Sinclair (2 shared papers)Hannah Lyons (1 shared paper)John Kirwan (1 shared paper)Ann Wendy Morgan (3 shared papers)Raashid Ahmed Luqmani (3 shared papers)Sarah Mackie (3 shared papers)Jessica J. Manson (2 shared papers)
- Journals
- Lara D. Veeken (6 papers)The Lancet (4 papers)The Lancet Rheumatology (3 papers)Eye (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesVietnam
In The Last Decade
Vanessa Quick
21 papers receiving 1.2k citations
Vanessa Quick's Hit Papers
Peers
Comparison fields: 5 of 84
- Infectious Diseases 756
- Applied Microbiology and Biotechnology 34
- Internal Medicine 27
- Rheumatology 98
- Hematology 59
Countries citing papers authored by Vanessa Quick
This map shows the geographic impact of Vanessa Quick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Quick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Quick more than expected).
Fields of papers citing papers by Vanessa Quick
This network shows the impact of papers produced by Vanessa Quick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Quick. The network helps show where Vanessa Quick may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanessa Quick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 3 | 2021 | 213 | |
| 4 | Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial Hit paper breakdown → | 2024 | 124 |
| 5 | 2021 | 72 | |
| 6 | 2019 | 52 | |
| 7 | 2023 | 24 | |
| 8 | 2013 | 16 | |
| 9 | 2018 | 16 | |
| 10 | 2023 | 14 | |
| 11 | 2012 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2018 | 4 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2018 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2019 | 1 |
About Vanessa Quick
Vanessa Quick is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Hematology, Rheumatology and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Vasculitis and related conditions (11 papers), COVID-19 Clinical Research Studies (4 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Pregnancy and Medication Impact (1 paper), Systemic Lupus Erythematosus Research (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (756 citations), Applied Microbiology and Biotechnology (34 citations), Internal Medicine (27 citations), Rheumatology (98 citations) and Hematology (59 citations). Vanessa Quick has collaborated with scholars based in United Kingdom, United States and Vietnam. Frequent co-authors include Susan P. Mollan, Alexandra Jean Sinclair, Hannah Lyons, John Kirwan, Ann Wendy Morgan, Raashid Ahmed Luqmani, Sarah Mackie, Jessica J. Manson, Jim Buckley and Peter Lanyon. Their work appears in journals such as Lara D. Veeken, The Lancet, The Lancet Rheumatology, Eye and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.